May 26, 2022, 09:27 AM by

May 26, 2022, 01:00 AM by User Not Found

Bio-IT World | Proscia launches an automated quality-control application that leverages artificial intelligence to improve drug development; an end-to-end software and data management package aids antibody discovery; ArisGlobal acquires BI’s analytic system; a data cloud is used for increased statistical analysis efficiency; new products from SCIEX and Dotmatics, and more.

May 25, 2022, 13:14 PM by

uMotif – the patient-first data capture and decentralized clinical trials platform – announces $25.5m of new investment from a fund managed by Athyrium Capital Management LONDON and NEW YORK, May 25, 2022-- uMotif today announced a new investment of $25.5m from a fund managed by Athyrium Capital Management, LP, the New York-based investment firm. The new funding will support continued scale up of uMotif's unique patient-first software platform for clinical research.

May 25, 2022, 09:10 AM by

CD BioSciences introduces comprehensive solutions for GPCR expression based on various strategies and technique platforms to facilitate customers’ cutting-edge programs.

May 25, 2022, 09:10 AM by

STEMart expands its Biocompatibility Testing services and introduces biocompatibility evaluation of breathing gas pathways in medical devices.

May 25, 2022, 09:10 AM by

Amerigo Scientific now introduces HHD Broth to the life science research community.

May 25, 2022, 09:10 AM by

Creative Diagnostics recently introduces comprehensive services for antibody-dependent enhancement (ADE) assay.

May 25, 2022, 01:00 AM by User Not Found

Bio-IT World| Funding for data protection and security platforms, autologous cell therapies, rapid DNA sequencing, and more.

May 24, 2022, 14:14 PM by

HealthSparq Annual Consumer Survey Reveals Strong Support for Price Transparency Government Mandates

May 24, 2022, 09:26 AM by

May 24, 2022, 09:26 AM by

MMS Holdings Inc. (MMS) – a data-focused contract research organization (CRO) – announced a collaboration with THREAD® as its partner of choice for its decentralized clinical trial platform (DCT) and DCT-enabled services, solidifying MMS as a full-service DCT provider. The THREAD partnership is one initiative of many at MMS dedicated to accelerating a path toward adopting more patient-focused clinical trials

May 24, 2022, 09:26 AM by

The RSA Group, a leading life sciences executive search firm, has published the latest of its Talent Equity® Reports: Biosimilars 2022. The new report features interviews with leaders of biosimilars companies who give their unique insights into the challenges and opportunities facing this fast-growing sector and the leadership needed to grow the industry, including the power of creating strong in-house knowledge and evaluating where this talent already exists.

May 24, 2022, 09:26 AM by

May 24, 2022, 09:26 AM by

May 24, 2022, 09:26 AM by

May 24, 2022, 09:26 AM by

Qlucore, listed on Nasdaq First North, is delighted to announce a new collaboration in the field of precision diagnostics to develop solutions for improved clinical diagnostics of bladder cancer. Bladder cancer is the third classifier model co-operation launched by Qlucore in the area of solid tumours.

May 24, 2022, 08:00 AM by User Not Found

Bio-IT World | “I want to disabuse you of any illusion there exists black-box technologies where you can feed in data from multiple omics inputs and out comes interesting biology,” Shankar Subramaniam told the crowd in Boston earlier this month at the Bio-IT World Conference and Expo. “That’s a myth.”

May 24, 2022, 01:00 AM by User Not Found

Bio-IT World | Dr. Kim Branson’s long-standing fascination with small molecule drug discovery and structural biology led to an established career in machine learning. After studying in Australia, Branson trained at Stanford and now works as the Senior Vice President and Global Head of AI/ML at GlaxoSmithKline (GSK). In the latest episode of Bio-IT World’s Trends from the Trenches podcast, Branson and host, Stan Gloss, discuss machine learning, human genetics, functional genomics, and how each predicts various aspects of health.

May 20, 2022, 09:10 AM by

mdgroup Growth sees New VP, Product Delivery, Investing for the Future Bracknell, UK: 19 May 2022 – mdgroup, the leading global provider of healthcare technologies and personalised clinical study services, has charged its new VP, Product Delivery, Mohamad (Mo) Merhi, with doubling the development team and recruiting the highest calibre of global talent in technological development and innovation.

May 20, 2022, 09:10 AM by

BioMoti Ltd today announces an agreement with a global pharmaceutical company to collaborate on the development of its lead ovarian cancer candidate, BMT101, to clinical phase 2a proof-of-concept.